Moreover, it can reduce angiogenesis through the downregulation of vascular endothelial growth factor and its receptors, and delay cell growth by obstructing the EGFR/AKT/protein kinase B/GSK3 signaling pathway in liver cancer (Huh7 and Hep G2) cells [685]. This evidence concerns the gene AKT1 and liver cancer.